Jay Pandya, MD

About

Book an Appointment with Jay Pandya, MD

New Patient Existing Patient

Born and raised in the Chicago area, Dr. Jay Pandya earned his medical degree from Rush Medical College, and went on to complete a cardiology fellowship at Northwestern University in Chicago. He then completed a second fellowship in interventional cardiology at the University of Illinois, where he was trained in advanced coronary and peripheral vascular/arterial interventions. At that time he was mentored in advanced radial artery catheterization techniques, and now performs the vast majority of his heart procedures through the wrist, as well as many of his peripheral vascular procedures. In addition to being a specialist in minimally invasive peripheral arterial interventions, Dr Pandya also provides complex percutaneous therapy for advanced venous conditions, including treatment for DVTs (blood clots in the arms/legs), pulmonary embolisms (blood clots in the lung), venous ulcers, and varicose veins. Dr. Pandya believes a major role for physicians is to educate patients on their condition, as well as on potential treatment options. In his spare time, he enjoys being with his family, traveling, hiking, music, and mountain biking.

Office Location:

Harker Heights
Round Rock

Media Features:

• Seton uses low-risk procedure to diminish blood clots - March 15, 2015 (The Killeen Daily Herald, Killeen, TX)

Publications:

• PANDYA SB, Kim YH, Meyers SN, Davidson CJ, Flaherty JD, Park DW, Mediratta A, Pieper K, Reyes E, Bonow RO, Park SJ, Beohar N. Drug-Eluting Stents versus Bare Metal Stents in Unprotected Left Main Coronary Artery Stenosis: a Meta-Analysis, Journal of the American College of Cardiology: Cardiovascular Interventions, June 2010; Vol 3 No 6: 602-611
• Beohar N, Rapp J, PANDYA SB, Losordo DW. Rebuilding the Damaged Heart: The Role of Cytokines and Growth Factors in the Treatment of Ischemic Heart Disease, Journal of the American College of Cardiology, October 2010; Vol 56, No 16: 1287-1297
• Rajamannan NM, Nealis TB, Subramanian M, PANDYA SB, Stock S, Ignatiev CI, Sebo TJ, Rosengart T, Edwards WD, McCarthy PM, Bonow RO, Spelsberg TC. Calcified Rheumatic Valve Neoangiogenesis Is Associated With Vascular Endothelial Growth Factor Expression and Osteoblast-Like Bone Formation, Circulation 2005; 111: 3296 - 3301
• Rajaram V, PANDYA SB, Patel S, Meyer PM, Goldin M, Feinstein MJ, Neems R, Liebson PR, Fiedler BM, Macioch JE, Feinstein SB. Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy, American Journal of Cardiology 2004; 93(11A): 32C-48C
• Patel SN, Rajaram V, PANDYA SB, Fiedler BM, Bai CJ, Neems R, Feinstein M, Goldin M, Feinstein SB. Emerging, Noninvasive Surrogate Markers of Atherosclerosis, Current Atherosclerosis Reports 2004; 6(1): 60-8

Abstracts:

• Rajamannan NM, Gallagher PS, Le TA, PANDYA SB, MConnel J, Singh R, Gocek J, Caira F, Subramaniam M, Spelsberg TC. Atorvastatin Attenuates Vascular Glomeruli Atherosclerosis in Experimental Hypercholesterolemia., Journal of the American College of Cardiology. 2005; 45(3) Supplement 1:A367

Presentations:

• PANDYA SB, Subramanian M, Stock S, Spelsberg TC, McCarthy P, Bonow RO, Rajamannan NM. Degenerative Versus Rheumatic Mitral Valve Disease: A Comparison of Cellular Proliferation and Osteoblast Mediated Extracellular Matrix Production, American College of Cardiology Scientific Session Orlando, FL March 2005
• PANDYA SB, Subramanian M, Stock S, Spelsberg TC, McCarthy P, Bonow RO, Rajamannan NM. Human Mitral Valve Degeneration is Associated with an Osteoblast Phenotype, Central Society for Clinical Research / Midwestern Section American Federation for Medical Research Chicago IL March, 2005